Bernstein on Biohaven Pharmaceutical Holding (BHVN): 'BHVN Remains One of Our Top Picks'
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering reiterated an Outperform rating and $63.00 price target on Biohaven Pharmaceutical Holding (NYSE: BHVN).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
